Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 12 of 12 entries
View as:

Phase I Study of Topical CRx-191 in Normal Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00544687 Org: User:
Start: 09/30/07 End: 11/30/07 Due: 11/30/08

A Single-Center Exploratory Study to Assess the Activity of CRx-197-002 in Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00796211 Org: User:
Start: 11/30/08 End: 01/31/09 Due: 01/31/10

Long Term Safety Trial of z102 and Prednisone in Patients With Moderate to Severe Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01612377 Org: User:
Start: 03/31/12 End: 09/30/13 Due: 09/30/14

Multicenter Study to Evaluate CRx-102 vs. Each of Its Components to Treat Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00551707 Org: User:
Start: 10/31/07 End: 01/31/09 Due: 01/31/10

CRx-102 Osteoarthritis Multicenter Evaluation Trial

Phase: N/A Priority: Normal
NCT ID: NCT00521989 Org: User:
Start: 08/31/07 End: 07/31/09 Due: 07/31/10

A Phase I Study to Assess the Safety and Tolerability of Topical CRx-197 Formulations in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00721331 Org: User:
Start: 07/31/08 End: 09/30/08 Due: 09/30/09

A Phase II Trial Comparing Z-102 With Placebo In Patients With Moderate To Severe Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01369745 Org: User:
Start: 06/30/11 End: 09/30/12 Due: 09/30/13

Efficacy and Safety Study of Z160 in Subjects With Postherpetic Neuralgia

Phase: N/A Priority: Normal
NCT ID: NCT01757873 Org: User:
Start: 12/31/12 End: 11/30/13 Due: 11/30/14

Study of CRx-401 on Glucose Levels in Subjects With Type II Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00506298 Org: User:
Start: 07/31/07 End: 05/31/09 Due: 05/31/10

Study of CRx-191 to Assess Activity in Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00557739 Org: User:
Start: 11/30/07 End: 01/31/08 Due: 01/31/09

A Study Comparing CRx-102 Plus Disease-modifying Anti-rheumatic Drug (DMARD) Therapy to Placebo Plus DMARD Therapy in RA

Phase: N/A Priority: Normal
NCT ID: NCT00747214 Org: User:
Start: 11/30/04 End: 11/30/06 Due: 11/30/07

Phase 2 Efficacy Trial of Z160 in Lumbosacral Radiculopathy

Phase: N/A Priority: Normal
NCT ID: NCT01655849 Org: User:
Start: 08/31/12 End: 11/30/13 Due: 11/30/14